Interfacial Injection in Low Back Pain
CompletedNot applicableNCT05396508
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Its effect on thoracolumbar fascia and low back pain has been investigated in different studies.These studies suggest that the anatomical and histological features of the fascia may have an effect on low back pain. This study aimed to investigate the effectiveness of interfacial injection in patients with chronic back pain.
Study details
- Official title
- The Effectiveness of Interfacial Injection Applied in Addition to Physical Therapy Applications in Chronic Low Back Pain
- Conditions
- Interventions
- Procedure: interfacial injection
- Procedure: physical therapy
- Sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Start date
- 2019-04-01
- Primary completion
- 2022-01-01
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Low back pain for more than 6 months; * Presence of MR findings radiologically diagnosing LDH; * Numeric rating scale (NRS) \> 5 Exclusion Criteria: * Spinal stenosis; * Spondylolisthesis; * Previous lumbar * Spinal surgery
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05396508